LEPR and Alzheimer disease: This is consistent with previous data obtained from the Alzheimer's Disease Neuroimaging Initiative (ADNI) cohort study, which showed decreased LepR immunoreactivity in brains from individuals suffering severe AD, and similarly the LepR mRNA was also reduced only in the old AD transgenic mice (Maioli et al., 2015).